Smith & Nephew (SNNUF) Equity Ratio (2015 - 2025)
Smith & Nephew (SNNUF) posted Equity Ratio of 0.51 for Q4 2025, down 0.53% on a QoQ basis from 0.51 in Q4 2024, and down 0.53% year-over-year from 0.51 in Q4 2024.
Smith & Nephew (SNNUF) has 11 years of Equity Ratio data on file, last reported at 0.51 in Q4 2025.
- In Q4 2025, Equity Ratio fell 0.53% year-over-year to 0.51; the TTM figure through Dec 2025 stood at 0.51 (down 0.53% YoY), while the FY2025 annual figure was 0.51, down 0.53% from the prior year.
- Equity Ratio slipped to 0.51 in Q4 2025, from 0.51 in the prior quarter.
- Across five years, Equity Ratio topped out at 652.12 in Q4 2023 and bottomed at 0.51 in Q4 2025.
- A 5-year average of 300.42 and a median of 292.17 in 2022 frame the typical range for Equity Ratio.
- Annual changes were most pronounced in 2023 — Equity Ratio surged 123.2% — and 2024, when it tumbled 99.92%.
- Year by year, Equity Ratio stood at 556.8 in 2021, then tumbled by 47.53% to 292.17 in 2022, then surged by 123.2% to 652.12 in 2023, then tumbled by 99.92% to 0.51 in 2024, then decreased by 0.53% to 0.51 in 2025.
- The last three Equity Ratio figures came in at 0.51 (Q4 2025), 0.51 (Q4 2024), and 652.12 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Smith & Nephew | - | - | - | 0.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.51 |
| Dec 31, 2024 | 0.51 |
| Dec 31, 2023 | 652.13 |
| Dec 31, 2022 | 292.17 |
| Dec 31, 2021 | 556.80 |
| Dec 31, 2020 | 586.56 |
| Dec 31, 2019 | 734.43 |
| Dec 31, 2018 | 143.35 |
| Dec 31, 2017 | 221.14 |
| Dec 31, 2016 | 0.54 |
| Dec 31, 2015 | 0.55 |